Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
or

Johnson & Johnson (JNJ)

Johnson & Johnson (JNJ)
164.11 +0.48 (+0.29%) 10:15 ET [NYSE]
164.08 x 150 164.16 x 53
Realtime by (Cboe BZX)
164.08 x 150 164.16 x 53
Realtime 163.40 -0.23 (-0.14%) 09:29 ET
Quote Overview for Mon, Mar 24th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
162.67
Day High
164.26
Open 162.84
Previous Close 163.63 163.63
Volume 658,877 658,877
Avg Vol 9,181,897 9,181,897
Stochastic %K 28.35% 28.35%
Weighted Alpha +6.87 +6.87
5-Day Change +1.34 (+0.82%) +1.34 (+0.82%)
52-Week Range 140.68 - 169.99 140.68 - 169.99
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 394,323,456
  • Shares Outstanding, K 2,409,848
  • Annual Sales, $ 88,821 M
  • Annual Income, $ 14,066 M
  • EBIT $ 14,023 M
  • EBITDA $ 21,362 M
  • 60-Month Beta 0.47
  • Price/Sales 4.42
  • Price/Cash Flow 12.42
  • Price/Book 5.49

Options Overview Details

View History
  • Implied Volatility 17.68% ( -0.82%)
  • Historical Volatility 15.25%
  • IV Percentile 63%
  • IV Rank 46.50%
  • IV High 23.61% on 01/10/25
  • IV Low 12.53% on 05/09/24
  • Put/Call Vol Ratio 0.47
  • Today's Volume 1,987
  • Volume Avg (30-Day) 36,910
  • Put/Call OI Ratio 0.53
  • Today's Open Interest 383,046
  • Open Int (30-Day) 450,602

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 22 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 2.59
  • Number of Estimates 7
  • High Estimate 2.66
  • Low Estimate 2.51
  • Prior Year 2.71
  • Growth Rate Est. (year over year) -4.43%

Price Performance

See More
Period Period Low Period High Performance
1-Month
161.10 +1.91%
on 03/14/25
Period Open: 163.74
169.99 -3.42%
on 03/04/25
+0.44 (+0.27%)
since 02/24/25
3-Month
140.68 +16.70%
on 01/10/25
Period Open: 145.85
169.99 -3.42%
on 03/04/25
+18.33 (+12.57%)
since 12/24/24
52-Week
140.68 +16.70%
on 01/10/25
Period Open: 155.23
169.99 -3.42%
on 03/04/25
+8.95 (+5.77%)
since 03/22/24

Most Recent Stories

More News
Take the Zacks Approach to Beat the Markets: CMS Energy, Chevron, AutoZone in Focus

Last week, the Nasdaq Composite and the S&P 500 declined 0.14% and 0.13%, respectively. The Dow Jones Industrial Average gained 0.34% in the same period. Investor sentiment is still hung upon President...

PPC : 50.66 (+2.90%)
PRMB : 32.77 (+1.49%)
CVX : 165.51 (+0.46%)
KO : 68.85 (+0.26%)
AZO : 3,648.14 (+1.16%)
JNJ : 164.24 (+0.37%)
TKOMY : 40.0350 (-0.41%)
CMS : 74.02 (+0.71%)
ICE : 174.73 (+0.19%)
SGIOY : 7.6300 (+0.79%)
UBER : 76.99 (+1.52%)
NOBL : 101.61 (+0.92%)
Here's How to Play JNJ Stock as it Announces $55B US Investment Plan

Last week, J&J JNJ announced plans to invest more than $55 billion over the next four years to expand its manufacturing footprint in the United States as the Trump administration considers imposing tariffs...

ITCI : 131.67 (+0.02%)
JNJ : 164.24 (+0.37%)
KVUE : 23.24 (-0.30%)
AMGN : 316.95 (+0.29%)
J&J to Invest $55B in United States to Boost Manufacturing, R&D

J&J JNJ announced plans to invest more than $55 billion in the United States over the next four years to boost manufacturing, R&D and technology in the country.  This represents a 25% increase in investment compared...

JNJ : 164.24 (+0.37%)
LLY : 847.47 (+1.18%)
PFE : 26.11 (-0.65%)
3 Dividend Stocks to Buy for a Safe Haven in This Volatile Market

The consistency in their dividend payments makes them dependable stocks in a volatile market.

NVDA : 119.75 (+1.74%)
KO : 68.85 (+0.26%)
$SPX : 5,753.17 (+1.51%)
PG : 166.25 (-0.26%)
JNJ : 164.24 (+0.37%)
Kenvue Stock In Focus As TOMS Capital Reportedly Pushes For Sale Or Breakup: Will It Shift Retail Mood?

Earlier this month, the company appointed three new directors, including Starboard Value CEO Jeffrey Smith, to its board as part of an agreement with the activist hedge fund after months of back-and-forth....

JNJ : 164.24 (+0.37%)
KVUE : 23.24 (-0.30%)
IPO : 40.03 (+2.46%)
FPX : 119.80 (+2.89%)
Stock market today: Wall Street closes higher, snapping a 4-week losing streak

U.S. stocks shook off a weak start and ended slightly higher, enough to break a four-week losing streak

NVDA : 119.75 (+1.74%)
AAPL : 220.00 (+0.79%)
$SPX : 5,753.17 (+1.51%)
JNJ : 164.24 (+0.37%)
MU : 98.14 (+3.61%)
NKE : 67.42 (-0.77%)
$IUXX : 20,131.62 (+1.91%)
DAL : 48.57 (+3.85%)
MSFT : 391.16 (-0.03%)
LMT : 431.37 (-1.89%)
DRI : 206.39 (+3.23%)
$DOWI : 42,474.13 (+1.16%)
Pharma Stock Roundup: PFE's Final Haleon Stake Sale, AZN, SNY M&A Deals

This week, the FDA approved J&J’s JNJ Tremfya for its second inflammatory bowel disease (“IBD”) condition, Crohn’s disease (“CD”), and Novartis’ NVS Fabhalta for its third indication, C3...

AZN : 74.37 (-0.75%)
JNJ : 164.24 (+0.37%)
NVS : 111.82 (-0.28%)
PFE : 26.11 (-0.65%)
SNY : 56.34 (-0.98%)
J&J's Tremfya Gets FDA Nod for 2nd IBD Condition Crohn's Disease

Johnson & Johnson JNJ announced that the FDA has granted approval to its key drug, Tremfya, for its second inflammatory bowel disease (IBD) condition — moderately to severely active Crohn’s disease...

JNJ : 164.24 (+0.37%)
MRK : 92.69 (-0.45%)
LLY : 847.47 (+1.18%)
ABBV : 210.96 (+0.45%)
Johnson & Johnson plans $55 billion in US investments over the next four years

Johnson & Johnson says it will invest more than $55 billion within the United States over the next four years, including four new manufacturing plants

AAPL : 220.00 (+0.79%)
$SPX : 5,753.17 (+1.51%)
JNJ : 164.24 (+0.37%)
$DOWI : 42,474.13 (+1.16%)
$IUXX : 20,131.62 (+1.91%)
Pfizer Sells Remaining 7.3% Stake in Haleon for Around 3.3B

Pfizer PFE has sold off its remaining stake in consumer health company Haleon HLN to institutional investors and Haleon itself for around $3.3 billion. Pfizer sold its 7.3% stake in Haleon, or approximately...

JNJ : 164.24 (+0.37%)
HLN : 10.17 (-1.07%)
GSK : 38.86 (-0.97%)
PFE : 26.11 (-0.65%)
Cabot's Shares Reach Fresh 52-Week High: What's Driving It?

Cabot Corporation‘s CBT shares reached a fresh 52-week high of $110.98 on Sept. 18 before closing at $107.85.CBT’s stock has appreciated 55.8% in the past year against the industry’s 4.3% fall.Image...

CBT : 83.69 (+1.80%)
IAG : 6.07 (+0.50%)
EGO : 15.57 (-0.45%)
HWKN : 107.95 (+2.06%)
Cabot: Fiscal Q3 Earnings Snapshot

Cabot: Fiscal Q3 Earnings Snapshot

CBT : 83.69 (+1.80%)
Cabot: Fiscal Q2 Earnings Snapshot

Cabot: Fiscal Q2 Earnings Snapshot

CBT : 83.69 (+1.80%)
Cabot: Fiscal Q1 Earnings Snapshot

Cabot: Fiscal Q1 Earnings Snapshot

CBT : 83.69 (+1.80%)
Cabot: Fiscal Q4 Earnings Snapshot

Cabot: Fiscal Q4 Earnings Snapshot

CBT : 83.69 (+1.80%)
Retail News, Vegas Happenings, and a China Check-In

A real estate bankruptcy shakes confidence in China and consumers across the globe focus on lower-priced items.

WMT : 86.83 (+0.99%)
MCD : 305.65 (+0.07%)
TGT : 105.57 (+1.45%)
MGM : 32.32 (+2.86%)
CBT : 83.69 (+1.80%)
VICI : 31.88 (+1.11%)
TMUS : 259.84 (+1.56%)
META : 617.63 (+3.59%)
NFLX : 959.81 (-0.05%)
MSFT : 391.21 (-0.01%)
AMZN : 202.32 (+3.11%)
WEN : 15.01 (-1.64%)
Cabot: Fiscal Q3 Earnings Snapshot

Cabot: Fiscal Q3 Earnings Snapshot

CBT : 83.69 (+1.80%)
10 Best Natural Gas Stocks to Buy Now

A nonrenewable resource, natural gas offers a lower-carbon alternative to traditional energy sources. Should you invest in natural gas? Learn more.

CHK : 81.46 (-0.96%)
AR : 41.44 (+1.64%)
CBT : 83.69 (+1.80%)
COG : 22.25 (+2.25%)
LNG : 233.25 (+2.83%)
CHKAQ : 3.0500 (+1.67%)
XEC : 87.20 (-3.11%)
DVN : 36.96 (+2.24%)
EQT : 54.20 (+2.50%)
RRC : 40.85 (+2.43%)
SWN : 7.11 (-0.56%)
WMB : 61.16 (+2.62%)
Adobe, Virgin Galactic rise; Humana, Cabot fall, Friday, 6/16/2023

Stocks that traded heavily or had substantial price changes on Friday: Adobe, Virgin Galactic rise; Humana, Cabot fall

ADBE : 395.83 (+2.21%)
HUM : 269.13 (+1.11%)
CBT : 83.69 (+1.80%)
DIS : 99.07 (-0.39%)
IRBT : 3.41 (+3.96%)
STLD : 127.00 (+3.53%)
SPCE : 3.99 (-2.68%)
AMZN : 202.32 (+3.11%)
Cabot: Fiscal Q2 Earnings Snapshot

Cabot: Fiscal Q2 Earnings Snapshot

CBT : 83.69 (+1.80%)
Cabot's Shares Reach Fresh 52-Week High: What's Driving It?

Cabot Corporation‘s CBT shares reached a fresh 52-week high of $110.98 on Sept. 18 before closing at $107.85.CBT’s stock has appreciated 55.8% in the past year against the industry’s 4.3% fall.Image...

CBT : 83.69 (+1.80%)
IAG : 6.07 (+0.50%)
EGO : 15.57 (-0.45%)
HWKN : 107.95 (+2.06%)
Cabot: Fiscal Q3 Earnings Snapshot

Cabot: Fiscal Q3 Earnings Snapshot

CBT : 83.69 (+1.80%)
Cabot: Fiscal Q2 Earnings Snapshot

Cabot: Fiscal Q2 Earnings Snapshot

CBT : 83.69 (+1.80%)
Cabot: Fiscal Q1 Earnings Snapshot

Cabot: Fiscal Q1 Earnings Snapshot

CBT : 83.69 (+1.80%)
Cabot: Fiscal Q4 Earnings Snapshot

Cabot: Fiscal Q4 Earnings Snapshot

CBT : 83.69 (+1.80%)
Retail News, Vegas Happenings, and a China Check-In

A real estate bankruptcy shakes confidence in China and consumers across the globe focus on lower-priced items.

WMT : 86.83 (+0.99%)
MCD : 305.65 (+0.07%)
TGT : 105.57 (+1.45%)
MGM : 32.32 (+2.86%)
CBT : 83.69 (+1.80%)
VICI : 31.88 (+1.11%)
TMUS : 259.84 (+1.56%)
META : 617.63 (+3.59%)
NFLX : 959.81 (-0.05%)
MSFT : 391.21 (-0.01%)
AMZN : 202.32 (+3.11%)
WEN : 15.01 (-1.64%)
Cabot: Fiscal Q3 Earnings Snapshot

Cabot: Fiscal Q3 Earnings Snapshot

CBT : 83.69 (+1.80%)
10 Best Natural Gas Stocks to Buy Now

A nonrenewable resource, natural gas offers a lower-carbon alternative to traditional energy sources. Should you invest in natural gas? Learn more.

CHK : 81.46 (-0.96%)
AR : 41.44 (+1.64%)
CBT : 83.69 (+1.80%)
COG : 22.25 (+2.25%)
LNG : 233.25 (+2.83%)
CHKAQ : 3.0500 (+1.67%)
XEC : 87.20 (-3.11%)
DVN : 36.96 (+2.24%)
EQT : 54.20 (+2.50%)
RRC : 40.85 (+2.43%)
SWN : 7.11 (-0.56%)
WMB : 61.16 (+2.62%)
Adobe, Virgin Galactic rise; Humana, Cabot fall, Friday, 6/16/2023

Stocks that traded heavily or had substantial price changes on Friday: Adobe, Virgin Galactic rise; Humana, Cabot fall

ADBE : 395.83 (+2.21%)
HUM : 269.13 (+1.11%)
CBT : 83.69 (+1.80%)
DIS : 99.07 (-0.39%)
IRBT : 3.41 (+3.96%)
STLD : 127.00 (+3.53%)
SPCE : 3.99 (-2.68%)
AMZN : 202.32 (+3.11%)
Cabot: Fiscal Q2 Earnings Snapshot

Cabot: Fiscal Q2 Earnings Snapshot

CBT : 83.69 (+1.80%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Strengthening short term outlook on maintaining the current direction.

See More Share

Business Summary

Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. Its diversification helps it to withstand economic cycles more effectively. J&J has one of the largest research and development (R&D) budget among...

See More

Key Turning Points

3rd Resistance Point 166.00
2nd Resistance Point 165.06
1st Resistance Point 164.35
Last Price 164.14
1st Support Level 162.70
2nd Support Level 161.76
3rd Support Level 161.05

See More

52-Week High 169.99
Last Price 164.14
Fibonacci 61.8% 158.79
Fibonacci 50% 155.33
Fibonacci 38.2% 151.88
52-Week Low 140.68

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Precision Trading with Bollinger Bands: Identifying Breakouts & Reversals

Info When You Need It Most.

Barchart Premier is one of the most powerful tools in the investment world. Come see why so many subscribers love it — and try it risk-free for 30 days.